UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000008423
Receipt No. R000009912
Scientific Title Single institute phase II study of neoadjuvant chemotherapy with trastuzumab and letrozole for postmenopausal ER-positive/HER2-positive breast cancers
Date of disclosure of the study information 2012/07/16
Last modified on 2020/03/15 14:58:52

No. Disposal Last modified on Item of update
1 Insert 2012/07/13 10:49:10
2 Update 2014/01/13 11:03:43 TEL
Email
Last name of contact person
Last name of contact person
Address
Address
Email
3 Update 2015/01/13 13:13:41 Organization
Organization
Organization1
Tel1
Email1
4 Update 2015/07/13 09:40:30 Key inclusion criteria
5 Update 2016/07/14 08:56:33 Name of primary sponsor
Organization
6 Update 2020/03/15 14:54:40 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date
7 Update 2020/03/15 14:56:21 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
8 Update 2020/03/15 14:58:52 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.